Case Report
Accepted on 25 Apr 2024
Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400097
Volumes
37,721 Publications
Volume 15 - 2024
Original Research
Accepted on 25 Apr 2024
PROTEIN KINASE CK2α IS OVEREXPRESSED IN CLASSICAL HODGKIN LYMPHOMA, REGULATES KEY SIGNALING PATHWAYS, PD-L1 AND MAY REPRESENT A NEW TARGET FOR THERAPY
Frontiers in Immunology
doi 10.3389/fimmu.2024.1393485
Editorial
Accepted on 25 Apr 2024
Editorial: New Insights into Cancer Immunology of Refractory GU and Liver Tumors: Therapy and Mechanism
Frontiers in Immunology
doi 10.3389/fimmu.2024.1420381
Review
Accepted on 25 Apr 2024
Glycan-Based Scaffolds and Nanoparticles as Drug Delivery System in Cancer Therapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395187
Original Research
Accepted on 25 Apr 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397827
Brief Research Report
Accepted on 25 Apr 2024
Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration
Frontiers in Immunology
doi 10.3389/fimmu.2024.1358800
Original Research
Accepted on 25 Apr 2024
The Atypical Chemokine Receptor 2 Reduces T Cell Expansion and Tertiary Lymphoid Tissue But Does Not Limit Autoimmune Organ Injury In Lupus-Prone B6lpr Mice
Frontiers in Immunology
doi 10.3389/fimmu.2024.1377913
Review
Accepted on 25 Apr 2024
Beyond Oncology: Selinexor's Journey into Anti-inflammatory Treatment and Long-term Management
Frontiers in Immunology
doi 10.3389/fimmu.2024.1398927
Original Research
Accepted on 25 Apr 2024
A Helping HAND: Therapeutic Potential of MAGL Inhibition Against HIV-1-associated Neuroinflammation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1374301
Original Research
Accepted on 25 Apr 2024
A Novel Humanized Mouse Model for HIV and Tuberculosis Co-infection Studies
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395018
Original Research
Accepted on 25 Apr 2024
Two new and effective food-extracted immunomodulatory agents exhibit antiinflammatory response activity in the hACE2 acute lung injury murine model of COVID-19
Frontiers in Immunology
doi 10.3389/fimmu.2024.1374541
Review
Accepted on 25 Apr 2024
Neutrophils in glioma microenvironment: from immune function to immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1393173
Original Research
Accepted on 25 Apr 2024
Consolidation therapy with autologous stem cell transplantation after remission of induction chemotherapy prolongs the survival of patients with Peripheral T-cell lymphoma
Frontiers in Immunology
doi 10.3389/fimmu.2024.1382189
Original Research
Accepted on 25 Apr 2024
Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model
Frontiers in Immunology
doi 10.3389/fimmu.2024.1279043
Original Research
Accepted on 25 Apr 2024
Pathogenic role of different phenotypes of immune cells in airway allergic diseases: a study based on Mendelian randomization (MR)
Frontiers in Immunology
doi 10.3389/fimmu.2024.1349470
Review
Accepted on 25 Apr 2024
Application of CD38 monoclonal antibody in kidney disease
Frontiers in Immunology
doi 10.3389/fimmu.2024.1382977